Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D019386 |
Alendronate |
Alendronate affects the expression of SLC6A4 mRNA | affects expression | 16079270
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC6A4 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
SLC6A4 gene polymorphism affects the susceptibility to Dextroamphetamine | affects response to substance | 16966188
|
D001151 |
Arsenic |
Arsenic results in increased expression of SLC6A4 mRNA | increases expression | 18315880
|
D010133 |
p-Chloroamphetamine |
p-Chloroamphetamine results in decreased expression of SLC6A4 mRNA | decreases expression | 16054768
|
D010133 |
p-Chloroamphetamine |
p-Chloroamphetamine results in decreased expression of SLC6A4 protein | decreases expression | 16054768
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in decreased expression of SLC6A4 | decreases expression | 17035140
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in decreased expression of SLC6A4 mRNA | decreases expression | 18835401
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in increased expression of SLC6A4 | increases expression | 17035140
|
D015283 |
Citalopram |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D015283 |
Citalopram |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D015283 |
Citalopram |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D015283 |
Citalopram |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D015283 |
Citalopram |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D003024 |
Clozapine |
[SLC6A4 gene polymorphism results in decreased uptake of Serotonin] which results in decreased susceptibility to Clozapine | decreases response to substance|decreases uptake | 20452607
|
D003024 |
Clozapine |
SLC6A4 protein affects the susceptibility to Clozapine | affects response to substance | 20452607
|
D003024 |
Clozapine |
Clozapine results in increased expression of SLC6A4 | increases expression | 12007678
|
D003976 |
Diazinon |
Diazinon results in decreased expression of SLC6A4 mRNA | decreases expression | 18835401
|
D003976 |
Diazinon |
Diazinon results in decreased expression of SLC6A4 protein | decreases expression | 17035140
|
D003976 |
Diazinon |
Diazinon results in increased expression of SLC6A4 protein | increases expression | 17035140
|
D019259 |
Lamivudine |
[Lamivudine co-treated with IFNA2 protein] results in increased expression of SLC6A4 mRNA | affects cotreatment|increases expression | 16476009
|
D019259 |
Lamivudine |
Lamivudine promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin] | increases reaction|increases uptake | 16476009
|
D019259 |
Lamivudine |
Lamivudine results in increased expression of and results in increased activity of SLC6A4 protein | increases activity|increases expression | 16476009
|
D019259 |
Lamivudine |
Lamivudine results in increased expression of SLC6A4 mRNA | increases expression | 16476009
|
D004026 |
Dieldrin |
Dieldrin results in decreased expression of SLC6A4 mRNA | decreases expression | 18835401
|
D015116 |
5,7-Dihydroxytryptamine |
5,7-Dihydroxytryptamine results in decreased expression of SLC6A4 protein | decreases expression | 16054768
|
D004298 |
Dopamine |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D004298 |
Dopamine |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D004298 |
Dopamine |
SLC6A4 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
C074283 |
estradiol 3-benzoate |
estradiol 3-benzoate results in increased expression of SLC6A4 protein | increases expression | 17398000
|
C074283 |
estradiol 3-benzoate |
Raloxifene inhibits the reaction [estradiol 3-benzoate results in increased expression of SLC6A4 protein] | decreases reaction|increases expression | 17398000
|
D004958 |
Estradiol |
[Estradiol co-treated with Sertraline] affects the expression of SLC6A4 mRNA | affects cotreatment|affects expression | 18650020
|
D004958 |
Estradiol |
Estradiol promotes the reaction [Sertraline results in increased expression of SLC6A4 mRNA] | increases expression|increases reaction | 18650020
|
D004958 |
Estradiol |
Estradiol results in increased expression of SLC6A4 mRNA | increases expression | 18650020
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SLC6A4 mRNA | affects expression | 16079270
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of SLC6A4 gene | increases mutagenesis | 16495775
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of SLC6A4 | increases expression | 12007678
|
D012701 |
Serotonin |
Lamivudine promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin] | increases reaction|increases uptake | 16476009
|
D012701 |
Serotonin |
Ribavirin promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin] | increases reaction|increases uptake | 16476009
|
D012701 |
Serotonin |
SLC6A4 gene polymorphism affects the abundance of Serotonin | affects abundance | 17203304
|
D012701 |
Serotonin |
[SLC6A4 gene polymorphism results in decreased uptake of Serotonin] which results in decreased susceptibility to Clozapine | decreases response to substance|decreases uptake | 20452607
|
D012701 |
Serotonin |
SLC6A4 protein promotes the reaction [Serotonin results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
D012701 |
Serotonin |
SLC6A4 protein results in increased uptake of Serotonin | increases uptake | 20452607 16476009
|
D012701 |
Serotonin |
SLC6A4 protein results in increased uptake of Serotonin | increases uptake | 15972295
|
D017367 |
Serotonin Uptake Inhibitors |
SLC6A4 intron polymorphism affects the susceptibility to Serotonin Uptake Inhibitors | affects response to substance | 17018806
|
D017367 |
Serotonin Uptake Inhibitors |
SLC6A4 promoter polymorphism affects the susceptibility to Serotonin Uptake Inhibitors | affects response to substance | 17018806
|
D017367 |
Serotonin Uptake Inhibitors |
[Sertraline results in decreased expression of SLC6A4 protein] which results in decreased metabolism of Serotonin Uptake Inhibitors | decreases expression|decreases metabolic processing | 12151556
|
C418119 |
indatraline |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
C418119 |
indatraline |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
C418119 |
indatraline |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
C418119 |
indatraline |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
C418119 |
indatraline |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D008694 |
Methamphetamine |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D008694 |
Methamphetamine |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D008694 |
Methamphetamine |
SLC6A4 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
D018817 |
N-Methyl-3,4-methylenedioxyamphetamine |
N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC6A4 mRNA | decreases expression | 16054768 16489401
|
D018817 |
N-Methyl-3,4-methylenedioxyamphetamine |
N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC6A4 protein | decreases expression | 16054768
|
D016686 |
Monocrotaline |
Monocrotaline results in increased expression of SLC6A4 mRNA | increases expression | 17042913
|
D016686 |
Monocrotaline |
Sertraline inhibits the reaction [Monocrotaline results in increased expression of SLC6A4 mRNA] | decreases reaction|increases expression | 17042913
|
D009532 |
Nickel |
Nickel results in decreased expression of SLC6A4 mRNA | decreases expression | 18835401
|
D009638 |
Norepinephrine |
SLC6A4 protein promotes the reaction [Norepinephrine results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
D009661 |
Nortriptyline |
SLC6A4 promoter polymorphism affects the susceptibility to Nortriptyline | affects response to substance | 17018806
|
D009655 |
Octopamine |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D009655 |
Octopamine |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D009655 |
Octopamine |
SLC6A4 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
D017374 |
Paroxetine |
Paroxetine affects the expression of SLC6A4 mRNA | affects expression | 10575045
|
D017374 |
Paroxetine |
Paroxetine results in decreased expression of SLC6A4 mRNA | decreases expression | 10575045
|
C029261 |
phenethylamine |
SLC6A4 protein promotes the reaction [phenethylamine results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of SLC6A4 mRNA | decreases expression | 17426115
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SLC6A4 mRNA | increases expression | 18301758
|
D020849 |
Raloxifene |
Raloxifene affects the expression of SLC6A4 mRNA | affects expression | 16079270
|
D020849 |
Raloxifene |
Raloxifene inhibits the reaction [estradiol 3-benzoate results in increased expression of SLC6A4 protein] | decreases reaction|increases expression | 17398000
|
D012254 |
Ribavirin |
Ribavirin promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin] | increases reaction|increases uptake | 16476009
|
D012254 |
Ribavirin |
Ribavirin results in increased expression of and results in increased activity of SLC6A4 protein | increases activity|increases expression | 16476009
|
D012254 |
Ribavirin |
Ribavirin results in increased expression of SLC6A4 mRNA | increases expression | 16476009
|
C069723 |
RTI 55 |
RTI 55 binds to SLC6A4 protein | affects binding | 15972295
|
D020280 |
Sertraline |
Sertraline inhibits the reaction [Monocrotaline results in increased expression of SLC6A4 mRNA] | decreases reaction|increases expression | 17042913
|
D020280 |
Sertraline |
SLC6A4 promoter polymorphism results in increased susceptibility to Sertraline | increases response to substance | 12955294
|
D020280 |
Sertraline |
SLC6A4 protein affects the susceptibility to Sertraline | affects response to substance | 12955294
|
D020280 |
Sertraline |
Sertraline results in decreased expression of SLC6A4 protein | decreases expression | 18923402
|
D020280 |
Sertraline |
[Estradiol co-treated with Sertraline] affects the expression of SLC6A4 mRNA | affects cotreatment|affects expression | 18650020
|
D020280 |
Sertraline |
Estradiol promotes the reaction [Sertraline results in increased expression of SLC6A4 mRNA] | increases expression|increases reaction | 18650020
|
D020280 |
Sertraline |
Sertraline results in decreased expression of SLC6A4 protein | decreases expression | 12151556
|
D020280 |
Sertraline |
[Sertraline results in decreased expression of SLC6A4 protein] which results in decreased metabolism of Serotonin Uptake Inhibitors | decreases expression|decreases metabolic processing | 12151556
|
D020280 |
Sertraline |
Sertraline results in increased expression of SLC6A4 mRNA | increases expression | 18650020
|
C030820 |
tryptamine |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
C030820 |
tryptamine |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
C030820 |
tryptamine |
SLC6A4 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
D014439 |
Tyramine |
Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D014439 |
Tyramine |
indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]] | decreases reaction|increases activity|increases reaction | 17234900
|
D014439 |
Tyramine |
SLC6A4 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein] | increases activity|increases reaction | 17234900
|
C047426 |
venlafaxine |
SLC6A4 gene polymorphism affects the susceptibility to venlafaxine | affects response to substance | 17503984
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.17 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.54 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
8.04 | 16166738 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.04 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.85 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.85 | 14692618 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.49 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.09 | 16434500 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
4.81 | 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.67 | 12649775 14617031 16160616 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
7.87 | 17119214 16611668 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
7.87 | 16487989 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.22 | 17308373 17451421 |
MESH:D000437 |
Alcoholism |
marker/mechanism |
|
| 15520362 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.45 | 15800139 |
MESH:D000855 |
Anorexia |
|
N-Methyl-3,4-methylenedioxyamphetamine |
4.98 | 15146954 |
MESH:D001008 |
Anxiety Disorders |
marker/mechanism |
|
| |
MESH:D001008 |
Anxiety Disorders |
|
Citalopram |
9.04 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
Sertraline |
9.04 | 18822694 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.75 | 16251483 16835338 18414634 12569548 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.08 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.42 | 15885639 |
MESH:D020817 |
Asperger Syndrome |
marker/mechanism |
|
| 18197083 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.01 | 19371607 12928151 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 16721604 17203304 17280648 9152989 20649385 |
MESH:D001321 |
Autistic Disorder |
|
Citalopram |
3.42 | 19232924 18775368 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
3.42 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
3.42 | 8570775 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
3.42 | 8570775 15132762 18361446 18405062 19221690 17157402 18062943 |
MESH:D001321 |
Autistic Disorder |
|
Sertraline |
3.42 | 18775368 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
2.80 | 19483382 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
5.08 | 8112388 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.54 | 14991843 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.09 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
3.95 | 16436596 15144691 16651633 16357521 18412241 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
2.02 | 11859874 15770527 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.02 | 16675129 19861407 17018787 18497071 12948864 17289903 14630087 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.02 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.02 | 17049068 17261762 17242785 15775269 16837676 15572757 17595753 16912660 17440819 17952589 17893378 15758505 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.07 | 16111702 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.36 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
2.94 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
2.94 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
2.57 | 15504454 18922899 17687452 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
8.54 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.54 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
4.15 | 11179087 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
6.65 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.65 | 15775269 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.98 | 16973168 18022660 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
10.34 | 15215559 1977408 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
10.34 | 8216760 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.11 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
6.11 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.58 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Citalopram |
6.61 | 15782081 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
6.61 | 21254450 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.77 | 11677210 17681005 16105132 17110522 15861022 17333356 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.77 | 19176532 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.29 | 17157402 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
10.40 | 17123785 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
10.40 | 15800139 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.48 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.23 | 11575062 |
MESH:D003866 |
Depressive Disorder |
|
Citalopram |
16.35 | 15014590 |
MESH:D003866 |
Depressive Disorder |
|
Paroxetine |
16.35 | 17072103 15014590 |
MESH:D003866 |
Depressive Disorder |
|
Sertraline |
16.35 | 15014590 18822694 20305041 |
MESH:D003866 |
Depressive Disorder |
|
venlafaxine |
16.35 | 20305041 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
9.32 | 17474826 |
MESH:D003865 |
Depressive Disorder, Major |
|
Sertraline |
9.32 | 16968574 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.58 | 17100760 17244072 19470301 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.28 | 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
2.87 | 16402076 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.91 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
7.91 | 17451421 17308373 15920148 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
4.40 | 11488427 8112388 10446763 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.15 | 15331141 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
3.98 | 15040536 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.90 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.40 | 16487989 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.58 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.70 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
9.70 | 15860553 |
MESH:D004487 |
Edema |
|
Serotonin |
9.70 | 18841975 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.87 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
7.87 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.72 | 11473722 18566989 19148513 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
4.09 | 821787 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
11.08 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.08 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
11.08 | 17473493 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.16 | 6392382 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
3.57 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.33 | 18412241 16357521 16651633 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.26 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.29 | 20558911 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
4.20 | 16487989 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
4.75 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
4.75 | 12044531 15631357 15309715 16476009 15274664 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Ribavirin |
6.17 | 19749757 16476009 19749758 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.62 | 18467677 19772884 16221962 19176532 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.63 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
6.47 | 9296927 20032539 17530837 11141242 |
MESH:D015658 |
HIV Infections |
|
Nickel |
6.47 | 17263646 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
15.18 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Paroxetine |
15.18 | 14716179 |
MESH:D019584 |
Hot Flashes |
|
venlafaxine |
15.18 | 14716179 |
MESH:D006816 |
Huntington Disease |
|
Sertraline |
5.64 | 18403212 |
MESH:D006930 |
Hyperalgesia |
|
Alendronate |
4.41 | 16769263 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.84 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.11 | 17050553 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
10.52 | 16046005 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
10.52 | 17658665 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.05 | 9931084 16076760 11953799 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.05 | 15787275 17577099 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Monocrotaline |
5.20 | 16936438 17042913 14726295 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.16 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.42 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Dopamine |
8.83 | 6740701 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
8.83 | 6740701 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
9.08 | 10630421 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
9.08 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
6.07 | 16466525 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.07 | 17937319 |
MESH:D007249 |
Inflammation |
|
Nickel |
3.23 | 16166738 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.33 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.33 | 16306350 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.60 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.36 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.66 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
6.66 | 17379185 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.13 | 16973256 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.29 | 17339181 |
MESH:D008064 |
Lipidoses |
|
Citalopram |
12.04 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
12.04 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Sertraline |
12.04 | 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.16 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
4.22 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
4.22 | 15991261 |
MESH:D017114 |
Liver Failure, Acute |
|
venlafaxine |
5.06 | 19857765 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
6.68 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
6.68 | 8742319 9539021 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
6.68 | 15890375 16377806 20007298 |
MESH:D008133 |
Long QT Syndrome |
|
Serotonin Uptake Inhibitors |
6.13 | 20210726 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.80 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
2.80 | 6695378 17703301 16019985 16271038 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
3.66 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.66 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.80 | 16891317 17203775 11807958 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
estradiol 3-benzoate |
8.80 | 15375486 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
8.80 | 10838139 10767621 18041768 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.08 | 19453300 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.58 | 17943659 |
MESH:D001523 |
Mental Disorders |
|
Citalopram |
30.63 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
30.63 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
30.63 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Nortriptyline |
30.63 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Paroxetine |
30.63 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Sertraline |
30.63 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
venlafaxine |
30.63 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.09 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Tyramine |
7.98 | 10792367 |
MESH:D008881 |
Migraine Disorders |
|
venlafaxine |
7.98 | 18803445 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.15 | 15863610 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.12 | 1613127 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.16 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.12 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
1.97 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
3.67 | 15371236 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
12.59 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
12.59 | 15642760 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
12.59 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.15 | 16343187 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
4.63 | 8820588 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.63 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.02 | 16707424 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.34 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.28 | 16427766 11399458 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.20 | 16620997 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.02 | 17160924 16003739 16651423 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.01 | 17056641 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
3.90 | 15081274 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.33 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.33 | 20558911 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
marker/mechanism |
|
| 18197083 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Paroxetine |
10.72 | 17503984 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
venlafaxine |
10.72 | 17503984 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.58 | 17160924 |
MESH:D010024 |
Osteoporosis |
|
Alendronate |
6.97 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.97 | 15775268 19059307 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.87 | 17893378 17823083 15758505 15579764 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
4.50 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.50 | 19401270 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.32 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
3.37 | 16112328 16809432 11181820 17291500 11445065 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.81 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.60 | 15371236 6392382 16905509 |
MESH:D011041 |
Poisoning |
|
Diazinon |
3.99 | 17603234 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.53 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.79 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.79 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.79 | 15731164 16220300 16536755 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.64 | 21343184 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.92 | 15861022 16919318 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.57 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
8.21 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
8.21 | 11575062 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.15 | 15770314 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.19 | 19058328 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
4.25 | 11874814 17119214 16611668 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
4.49 | 17119214 16611668 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.14 | 9296927 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 18583979 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
3.87 | 18806925 20521320 20452607 20580759 11763009 16141801 20521326 17123785 17726453 17667964 18855531 11151749 20107430 19369910 20168265 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
3.87 | 1830565 18513383 20107430 19369910 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.69 | 6418539 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.64 | 16702368 18709164 16759981 17548696 16353154 17453740 19834688 15952646 6392382 17938729 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
2.82 | 17976673 17050553 17029826 16251483 15504454 19538983 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.54 | 16709447 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.51 | 16837676 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
5.06 | 3261545 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.33 | 20210726 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.26 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.82 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.77 | 15790496 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.37 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.37 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
4.85 | 17306315 18640142 17976673 15987713 11144890 19429237 19322015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
4.85 | 17572228 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.87 | 16487989 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.93 | 14692618 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.34 | 17056641 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.81 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.19 | 14671159 15869587 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.15 | 16343187 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.14 | 16402076 20107430 16141801 17502770 20564506 20521320 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.68 | 17933447 |